Molecular precision diagnostics – Detect more. Decide better.
Biotype is a German innovator in molecular diagnostics with over 25 years of experience. Since 1999, the company has been developing solutions for professional laboratories, pharmaceutical and biotech companies, and research institutions worldwide.
Their mission is to improve clinical decision-making by creating technologies that deliver the most comprehensive biomarker and genetic insights, enabling physicians and researchers to make more precise therapy choices.
Portfolio of Solutions
Biotype offers a broad range of high-quality products and services across key areas of molecular diagnostics:
- Hemato-oncology – detection of gene fusions in AML and other hematopoietic disorders.
- Chimerism monitoring – advanced tools for transplantation follow-up and engraftment analysis.
- Liquid biopsy – minimally invasive testing of biological fluids for real-time disease monitoring.
- Molecular profiling of solid tumors – rapid and sensitive analysis of mutations and biomarkers in tumor tissue.
- Forensic applications – optimized systems for DNA identification and analysis.
MODAPLEX Platform
A highlight of Biotype’s portfolio is MODAPLEX, a unique platform that combines PCR and capillary electrophoresis in one fully automated workflow. It enables comprehensive biomarker profiling with a turnaround time of just four hours, while significantly reducing hands-on work.